{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "currency": "KRW", "market": "kr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 32400000, "exchange": "KSC", "longName": "Prestige BioPharma Limited", "shortName": "PRESTIGE BIOPHARMA", "regularMarketPrice": 9450.0, "regularMarketChangePercent": 0.0, "messageBoardId": "finmb_423295388", "marketState": "PREPRE", "fiftyTwoWeekHighChangePercent": -0.53101736, "fiftyTwoWeekLow": 7020.0, "fiftyTwoWeekHigh": 20150.0, "fiftyTwoWeekLowChange": 2430.0, "fiftyTwoWeekLowChangePercent": 0.34615386, "fiftyTwoWeekRange": "7020.0 - 20150.0", "fiftyTwoWeekHighChange": -10700.0, "sharesOutstanding": 60096200, "fiftyDayAverage": 10963.2, "fiftyDayAverageChange": -1513.2002, "fiftyDayAverageChangePercent": -0.1380254, "twoHundredDayAverage": 9551.35, "twoHundredDayAverageChange": -101.34961, "twoHundredDayAverageChangePercent": -0.010611025, "marketCap": 567909089280, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1612828800000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683873030, "regularMarketDayHigh": 9730.0, "regularMarketDayRange": "9340.0 - 9730.0", "regularMarketDayLow": 9340.0, "regularMarketVolume": 38274, "regularMarketPreviousClose": 9450.0, "bid": 9410.0, "ask": 9440.0, "fullExchangeName": "KSE", "financialCurrency": "KRW", "regularMarketOpen": 9470.0, "averageDailyVolume3Month": 204807, "averageDailyVolume10Day": 64600, "symbol": "950210.KS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "21 Biopolis Road", "address2": "No. 04-24/28 Nucleos South Building", "city": "Singapore", "zip": "138567", "country": "Singapore", "phone": "65 6924 6535", "fax": "65 6924 2053", "website": "https://www.prestigebiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.", "companyOfficers": [{"maxAge": 1, "name": "Ms. So-Yeon  Park", "age": 59, "title": "Chairman & CEO", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lai Wat  Tay", "age": 66, "title": "CFO & Director", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael Jinwoo  Kim", "age": 58, "title": "COO & Director", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Chung Shii  Hii", "age": 43, "title": "Chief Technology Officer", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kay K.H.  Lee", "age": 52, "title": "Clinical Devel. Mang.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ghislain M.C  Bonamy", "age": 43, "title": "Gen. Mang. of Licensing", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}